HC Wainwright restated their buy rating on shares of Mustang Bio (NASDAQ:MBIO – Get Rating) in a report released on Thursday morning, Benzinga reports. The firm currently has a $7.00 target price on the stock. HC Wainwright also issued estimates for Mustang Bio’s Q1 2023 earnings at ($0.19) EPS, Q2 2023 earnings at ($0.20) EPS, […]
Mustang Bio, Inc. (NASDAQ:MBIO – Get Rating) was the recipient of a significant decline in short interest in March. As of March 15th, there was short interest totalling 144,400 shares, a decline of 45.3% from the February 28th total of 264,000 shares. Based on an average trading volume of 458,900 shares, the days-to-cover ratio is […]
Mustang Bio, Inc. (NASDAQ:MBIO – Get Rating) – Cantor Fitzgerald lifted their FY2022 earnings estimates for Mustang Bio in a research report issued to clients and investors on Monday, August 15th. Cantor Fitzgerald analyst K. Kluska now expects that the company will earn ($0.80) per share for the year, up from their previous forecast of […]